Clin2
NCT07411638Likely a fitNot yet recruiting

Acne study: looking at how skin changes in mild to severe acne

Acne

Part of Skin clinical trials.

This study is for people aged 18 to 25 with mild, moderate, or severe facial acne, and also for healthy volunteers without acne. Researchers want to learn more about acne by taking skin samples and blood samples, and no experimental treatments are given.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years to 25 years
Study type
Observational

Who can take part

  • You are between 18 and 25 years old.
  • You have either mild, moderate, or severe facial acne, or you have clear skin (no acne).
  • You are able to attend all study visits and follow the study rules.
  • You have not used oral isotretinoin (like Accutane) before.
  • You are not pregnant or breastfeeding, and you are willing to avoid certain acne treatments before the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07010458Not yet recruiting
Acne treatment study for adults

This study tests a new acne treatment in adults. It aims to see if the treatment works well and is safe for people with acne.

San Francisco, California
NCT03465150Recruiting
People with acne can join an acne patient study

This study creates a group (cohort) of patients treated for acne at a hospital to better understand acne care in real life. It may help improve future care by sharing what treatments people receive and how they do over time.

Nantes
NCT06716398Recruiting
A cosmetic study for teens and young adults with acne

This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.

São Paulo
NCT07013747Recruiting· Phase 1/Phase 2
Acne mRNA vaccine for mild acne

This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.

Encino, California
NCT06992154Not yet recruiting· Early Phase 1
Study of a gut bacteria supplement for acne

This trial tests whether a supplement containing a healthy gut bacteria called Akkermansia muciniphila can help treat moderate to severe acne. It aims to see if improving gut health can reduce acne breakouts.

NCT07756957Not yet recruiting· Phase 2
Acne vaccine for teenagers with moderate to severe acne

This trial tests an mRNA vaccine designed to target the bacteria that cause acne. It is for teenagers aged 12 to 17 with moderate to severe facial acne. The goal is to see if the vaccine is safe and may help reduce acne.

Hear when a new Acne trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.